In focus · trending topic

Infectious disease

25 stories · following the connections

Cempra’s Fusidic Acid Achieves Primary Endpoint in Phase 3 Study of ABSSSI

By Nasdaq OMXFeb 24, 2017, 12:00 PM UTC

Assembly Biosciences Announces Successful Completion of ABI-H0731 Phase 1a Trial and Upcoming Conference Presentations

By Nasdaq OMXFeb 16, 2017, 12:05 PM UTC

Great Basin Scientific’s Shiga Toxin Direct Test Clinical Evaluation and Cost Analysis Published in Journal of Clinical Microbiology

By Nasdaq OMXFeb 3, 2017, 12:00 PM UTC

Melinta Therapeutics’ New Drug Application for Baxdela Accepted for Filing by US FDA

By Nasdaq OMXJan 5, 2017, 1:01 PM UTC

Melinta Therapeutics’ New Drug Application for Baxdela Accepted for Filing by US FDA

By Nasdaq OMXJan 5, 2017, 1:01 PM UTC

Great Basin Scientific Submits 510(k) Application to the FDA for Stool Bacterial Pathogens Panel

By Nasdaq OMXDec 19, 2016, 12:30 PM UTC

Great Basin Scientific Granted U.S. Patent for PCR Amplification Suppressor

By Nasdaq OMXNov 29, 2016, 12:30 PM UTC

Great Basin Scientific to Demonstrate its Diagnostics Platform at AMP 2016

By Nasdaq OMXNov 10, 2016, 12:01 PM UTC